A medicine list: everything you take in one place
The list of medicines and supplements you keep at hand: yours, your mother's, your child's. For every pair from the list the reference shows an interaction entry where one exists, food and nutrients included.
An older person on five prescriptions from three doctors arrives at an appointment with a bag of boxes and half the names remembered by the colour of the packaging. The list keeps those names in one place, with a free-text dose and a mark for what is taken now and what was taken before. At the appointment the doctor opens a link and sees the whole list instead of what came to mind.
Want an email when the medicine list opens?
The medicine list is closed for now. One email at launch, no newsletters.
What it looks like
Mum's list
- Enalapril10 mg in the morningtaking now
- Spironolactone25 mg in the morningtaking now
- Ibuprofenas neededtaking now
- Sertraline50 mg at nighttook before
For enalapril + spironolactone the reference has an entry: both raise potassium
The list is generic, assembled for illustration. The medicine list shows reference information about the substances in it, not an analysis of your own case.
What it will do
- Several lists per account: yours, your mother's, your child's
- Status “taking now” or “took before”, free-text dosage
- Reference interaction entries for pairs from the list, food and nutrients included
- A4 print and a wallet card
- A read-only link to show your doctor, revocable in one click
What it will cost
One list, with its interaction entries, stays free
Several lists, print, and the doctor link will come with Pro at €4.99 a month
About the data
A list of medicines is health data, so we store the minimum: the name, the dose as text, and your note. We do not ask for sex, age, diagnoses, or allergies. Until you issue a link, only you can see the list. Deleting a list deletes its medicines too, at once and with no bin.
Leave your email and we will write when the medicine list opens
The medicine list is closed for now. One email at launch, no newsletters.